FNDC5 and coronary artery disorder: Consistent with previous reports demonstrating reduced circulating irisin levels in patients with stable CAD and inverse associations with disease severity [28, 29], our study also found significantly lower irisin concentrations in the CAD group compared to non-CAD participants (Figure S13).